Case Report

Treatment of a malignant peripheral nerve sheath tumor by intravenous administration of combretastatin A4-phosphate in a dog

Authors
  • S. De Vos
  • E. Abma
  • K. Vanderperren
  • L. Van Brantegem
  • W. De Spiegelaere
  • H. de Rooster

Abstract

A fifteen-year-old, male, castrated American Staffordshire terrier was presented with a subcutaneous, ulcerated mass on the right carpal joint. Thoracic radiographs and abdominal ultrasound were both negative for metastatic disease. Punch biopsies revealed the histopathological diagnosis of a malignant peripheral nerve sheath tumor. Due to the extent of the primary mass, local excision was not possible, and amputation of the limb was not an option for the owner. The dog was treated with intravenous administration of combretastatin A4-phosphate, a vascular disrupting agent. A biopsy was taken before and after treatment and power-Doppler ultrasound and contrast-enhanced ultrasound were performed to assess pre- and posttreatment evaluation of the tumor vasculature. The treatment resulted in massive necrosis of the tumor.

How to Cite:

De Vos, S. & Abma, E. & Vanderperren, K. & Van Brantegem, L. & De Spiegelaere, W. & de Rooster, H., (2018) “Treatment of a malignant peripheral nerve sheath tumor by intravenous administration of combretastatin A4-phosphate in a dog”, Vlaams Diergeneeskundig Tijdschrift 87(6), 326-332. doi: https://doi.org/10.21825/vdt.v87i6.16050

Downloads:
Download PDF
View PDF

429 Views

109 Downloads

Published on
27 Dec 2018
Peer Reviewed